2025 Cell Viability Assays Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Cell Viability Assays Market Size By 2025?
Over the recent years, the cell viability assays market has experienced swift growth. The market size which stood at $1.56 billion in 2024 is projected to climb up to $1.73 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.8%. The higher growth rate during the historic period can be traced back to factors such as an increase in cancer research investments, expansion in pharmaceutical R&D spending, the development of the biotechnology sector, progression in cell culture techniques, a surge in demand for stem cell research, growing necessity for toxicity testing, increased use of real-time cell analysis systems, and an escalation in the count of CROs (contract research organizations).

How Big Is the Cell Viability Assays Market Size Expected to Grow by 2029?
The market size of cell viability assays is projected to witness substantial growth in the coming years, reaching $2.58 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. Factors that can be held accountable for the growth during the forecast period include the growing demand for personalized medicine, an increase in government investment in cell-based research, a marked emphasis on precision medicine and stem cell research and applications, and increased availability of automated cell viability analyzers. Other factors include the rise in infectious diseases, a focus on enhancing the accuracy and sensitivity of assays, heightened awareness regarding the advantages of cell viability assays, and surge in the development of organ-on-a-chip technologies as well as regenerative medicine demands. Key trends for the forecast period include improvements in high throughput screening methods, application of AI and machine learning algorithms, creation of real-time monitoring systems, adoption of automated liquid handling systems, developing multiplex assays for simultaneous cell viability measurement, using sustainable and eco-friendly reagents, creation of user-friendly assay kits, advancements in electrochemical assays, application of scalable cell viability assays, and the development of assays compatible with primary and stem cells.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Key Market Drivers Powering Cell Viability Assays Market Expansion and Growth?
The growth of the cell viability assay market is anticipated to be boosted by the expanding use of cell-based therapeutics. These treatments utilize living cells to mend or replace damaged tissues, manage diseases, or restore regular function. Biotechnology advancements, escalated investment in regenerative medicine, a growing embrace and implementation of cell therapies, and enhancements in cell engineering and manufacturing technologies are all factors contributing to the rise of cell-based therapeutics. Cell viability assays, which ensure the wellness, functionality, and safety of therapeutic cells, are fundamental to cell-based therapeutics, enhancing treatment efficacy and offering quality control. As revealed by the American Society of Gene & Cell Therapy, a non-profit medical and scientific organization in the USA, there was an inauguration of 38 trials for non-genetically modified cell therapies in the first quarter of 2023, which is seven more compared to the last quarter of 2022. Consequently, the escalating application of cell-based therapeutics is fueling the expansion of the cell viability assay market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Cell Viability Assays Market?
Top-tier firms in the cell viability assays market are innovating cell screening technologies in a bid to boost precision and expedite the drug discovery process. They are enhancing cell viability assays with cell screening technologies to facilitate high-throughput, accurate, and quick cell health and response evaluation, thereby refining experimental conditions and bolstering the creation of therapeutic strategies. To illustrate, in May 2024, Arralyze, a tech enterprise based in Germany, launched CellShepherd, a sophisticated platform designed for single-cell analysis. The platform uses exclusive nanowell glass arrays to downsize cell-based assays for real-time observation. This independent system provides exact cell dispensing, co-culturing under sterile conditions, and imaging with brightfield and fluorescent channels. An AI-driven evaluation ensures precise cell counting and tracking. This intuitive platform caters to the growing demand for accurate single-cell research in biomedical and life sciences.

What Are the Emerging Segments in the Cell Viability Assays Market?
The cell viability assays market covered in this report is segmented -

1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:
1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates
2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Who Are the Global Leaders in the Cell Viability Assays Market?
Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, dic*kinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Which are the Top Profitable Regional Markets for the Cell Viability Assays Industry?
North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16014

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.